# Ann E. Clarke

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/ann-e-clarke/

## Facts

| Field | Value |
| --- | --- |
| Citations | 36,917 |
| Field | Systemic Lupus Erythematosus Research |
| h-index | 85 |
| i10-index | 319 |
| Last Known Institution | University of Calgary |
| OpenAlex ID | https://openalex.org/A5021381077 |
| ORCID iD | 0000-0002-3112-9646 |
| Works | 623 |

## Researcher papers

Showing 12 of 28.

- [Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus](https://scholariq.org/papers/derivation-and-validation-of-the-systemic-lupus-international-collaborating/)
- [2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus](https://scholariq.org/papers/2019-european-league-against-rheumatism-american-college-of-rheumatology/)
- [2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus](https://scholariq.org/papers/2019-european-league-against-rheumatism-american-college-of-rheumatology-2/)
- [Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus](https://scholariq.org/papers/traditional-framingham-risk-factors-fail-to-fully-account-for-accelerated/)
- [Mortality in systemic lupus erythematosus](https://scholariq.org/papers/mortality-in-systemic-lupus-erythematosus/)
- [A Comparison of Two Intensities of Warfarin for the Prevention of Recurrent Thrombosis in Patients with the Antiphospholipid Antibody Syndrome](https://scholariq.org/papers/a-comparison-of-two-intensities-of-warfarin-for-the-prevention-of-recurrent/)
- [Treat-to-target in systemic lupus erythematosus: recommendations from an international task force](https://scholariq.org/papers/treat-to-target-in-systemic-lupus-erythematosus-recommendations-from-an/)
- [Global epidemiology of systemic lupus erythematosus](https://scholariq.org/papers/global-epidemiology-of-systemic-lupus-erythematosus/)
- [The frequency and outcome of lupus nephritis: results from an international inception cohort study](https://scholariq.org/papers/the-frequency-and-outcome-of-lupus-nephritis-results-from-an-international/)
- [Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort](https://scholariq.org/papers/factors-associated-with-damage-accrual-in-patients-with-systemic-lupus/)
- [Loss-of-function variants in the filaggrin gene are a significant risk factor for peanut allergy](https://scholariq.org/papers/loss-of-function-variants-in-the-filaggrin-gene-are-a-significant-risk-factor/)
- [Timing of total joint replacement affects clinical outcomes among patients with osteoarthritis of the hip or knee](https://scholariq.org/papers/timing-of-total-joint-replacement-affects-clinical-outcomes-among-patients-with/)

## Researcher topics

- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Food Allergy and Anaphylaxis Research](https://scholariq.org/topics/food-allergy-and-anaphylaxis-research/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Allergic Rhinitis and Sensitization](https://scholariq.org/topics/allergic-rhinitis-and-sensitization/)
- [Systemic Sclerosis and Related Diseases](https://scholariq.org/topics/systemic-sclerosis-and-related-diseases/)

## Researcher university

- [University of Calgary](https://scholariq.org/institutions/university-of-calgary/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.